Cano Health Inc - Class A

CANO | $2.3 -49.13% 21K

(0.0% 1d) (0.0% 1m) (105.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 6,641,498
https://canohealth.com
Sec Filling | Patents | 2200 employees

(US) Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico.

add to watch list Paper trade email alert is off

Viridian Therapeutics Inc

VRDN | $13.04 -8.49% -9.28% 770K

Health Care and Social Assistan...

(0.0% 1d) (-18.8% 1m) (-49.5% 1y) (0.0% 2d) (-0.3% 3d) (-6.0% 7d) (-33.73% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 818,489,113
http://www.miragen.com/
Sec Filling | Patents | 27 employees

(US) Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.

treatment antibody

add to watch list Paper trade email alert is off